Collaborations

Omicia is collaborating with leaders in human genetics and clinicians to advance our science and technology.

Genomic Cancer Care Alliance

Omicia is part of the Genomic Cancer Care Alliance, an initiative organized by Life Technologies, Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute (TGen) to help people battling cancer gain access to treatment options found through analysis of their genomic information. The Alliance is conducting a pilot study aimed at determining whether whole-genome sequencing can better guide treatment decisions across a number of difficult-to-treat cancers. Omicia and TGen are providing interpretation for the genome sequencing results.

Mark Yandell, Ph.D., Associate Professor
Department of Human Genetics
University of Utah

Omicia is collaborating with Dr. Yandell on various projects to develop computational methods for discovering relationships between genes and diseases including a new software tools to technically annotate and interpret complete human genomes sequences with respect to clinical knowledge. In March 2011, we published our analysis of the first 10 publicly available human genome sequences in Genetics in Medicine.

Joel Bader, Ph.D., Associate Professor
Department of Biomedical Engineering
Johns Hopkins University

Drawing upon Omicia’s advanced understanding of disease genes and phenotypes and Dr. Bader’s expertise in gene interaction networks and model organism genetics, this collaboration involves the identification of genes whose variants increase the risk of developing cardiovascular disease.

Karen Eilbeck, Ph.D., Assistant Professor
Department for Biomedical Informatics, School of Medicine
University of Utah

Omicia is collaborating with Dr. Eilbeck to develop a variant ontology for disease annotations in personal genomes. Through this collaboration, we are developing a suite of tools to interrelate disease, gene and sequence ontologies. The initial focus of the collaboration is on sequence variants implicated in cardiovascular disease.